PharVision Advisers’s Nathan's Famous NATH Stock Holding History

PharVision Advisers’s Portfolio NATH Stock Details NATH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,228	Closed	-$208K	–	454
2025 Q4	$208K	Buy	+2,228	New	+$224K	0.11%	522

Other funds holding NATH

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

PharVision Advisers's NATH Position: Q1 2026 in Review

PharVision Advisers sold out of Nathan's Famous (NATH) in Q1 2026, closing a stake of 2,228 shares — an estimated $208K sold.

PharVision Advisers first reported a position in NATH in Q4 2025 and held it in 1 quarter. The position peaked at $208K in Q4 2025. 127 funds tracked by Wall St. Rank hold NATH as of Q1 2026.

PharVision Advisers reported no remaining Nathan's Famous position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,228 Nathan's Famous shares in Q1 2026, an estimated $208K.
PharVision Advisers first reported a position in Nathan's Famous in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Nathan's Famous position peaked at $208K in Q4 2025.
127 funds tracked by Wall St. Rank held Nathan's Famous as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.